{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:19:11Z","timestamp":1783552751730,"version":"3.55.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02872-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:01:08Z","timestamp":1783551668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Switching tumor-derived extracellular vesicles off and on via targeted proteolysis to shift toward immunogenic phenotypes"],"prefix":"10.1038","volume":"11","author":[{"given":"Yeongji","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeongmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Young","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hochung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3405-198X","authenticated-orcid":false,"given":"Jae-Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunbyeol","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-7754","authenticated-orcid":false,"given":"Kyungsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Cheol","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yeol","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-3278","authenticated-orcid":false,"given":"Jooho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangmeyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0001-6646","authenticated-orcid":false,"given":"Jun-Seob","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3279-4362","authenticated-orcid":false,"given":"Yoosoo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2135-2968","authenticated-orcid":false,"given":"Man Kyu","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2872_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Th\u00e9ry","year":"2002","unstructured":"Th\u00e9ry, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569\u2013579 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"2872_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/d41573-020-00220-y","volume":"20","author":"M Cully","year":"2021","unstructured":"Cully, M. Exosome-based candidates move into the clinic. Nat. Rev. Drug Discov. 20, 6\u20137 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2872_CR3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach, M. & Th\u00e9ry, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226\u20131232 (2016).","journal-title":"Cell"},{"key":"2872_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu, M., Martin-Jaular, L., Lavieu, G. & Th\u00e9ry, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9\u201317 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2872_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel, I., Dror, S., Kenific, C. M. & Lyden, D. Exosome-mediated metastasis: communication from a distance. Dev. Cell 49, 347\u2013360 (2019).","journal-title":"Dev. Cell"},{"key":"2872_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12031","volume":"10","author":"X Mao","year":"2020","unstructured":"Mao, X. et al. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells. J. Extracell. Vesicles 10, e12031 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"2872_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio, M. et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell 177, 414\u2013427. e413 (2019).","journal-title":"Cell"},{"key":"2872_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ymthe.2021.07.015","volume":"30","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Extracellular vesicle-mediated communication between hepatocytes and natural killer cells promotes hepatocellular tumorigenesis. Mol. Ther. 30, 606\u2013620 (2022).","journal-title":"Mol. Ther."},{"key":"2872_CR9","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res 28, 862\u2013864 (2018).","journal-title":"Cell Res"},{"key":"2872_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41563-023-01515-2","volume":"22","author":"S Shin","year":"2023","unstructured":"Shin, S. et al. Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy. Nat. Mater. 22, 656\u2013665 (2023).","journal-title":"Nat. Mater."},{"key":"2872_CR11","doi-asserted-by":"publisher","first-page":"2400762","DOI":"10.1002\/adma.202400762","volume":"36","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. Exosome-Inhibiting Polymeric Sonosensitizer for Tumor-Specific Sonodynamic Immunotherapy. Adv. Mater. 36, 2400762 (2024).","journal-title":"Adv. Mater."},{"key":"2872_CR12","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/s12276-022-00898-7","volume":"54","author":"JH Kim","year":"2022","unstructured":"Kim, J. H., Lee, C.-H. & Baek, M.-C. Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer. Exp. Mol. Med. 54, 1833\u20131843 (2022).","journal-title":"Exp. Mol. Med."},{"key":"2872_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.02.065","volume":"381","author":"J Kim","year":"2025","unstructured":"Kim, J. et al. Dual-delivery of exosome inhibitor and immune-activating gene via lipid nano-assemblies for tumor immune evasion inhibition. J. Control. Release 381, 113569 (2025).","journal-title":"J. Control. Release"},{"key":"2872_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-026-02736-y","volume":"11","author":"CH Kim","year":"2026","unstructured":"Kim, C. H. et al. Combating small extracellular vesicle\u2013mediated immunological barriers in the tumor microenvironment via strategically activatable PEGylated peptides. Signal Transduct. Target. Ther. 11, 200 (2026).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2872_CR15","doi-asserted-by":"publisher","first-page":"1901779","DOI":"10.1002\/advs.201901779","volume":"6","author":"F Xie","year":"2019","unstructured":"Xie, F. et al. Extracellular vesicles in cancer immune microenvironment and cancer immunotherapy. Adv. Sci. 6, 1901779 (2019).","journal-title":"Adv. Sci."},{"key":"2872_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/85438","volume":"7","author":"J Wolfers","year":"2001","unstructured":"Wolfers, J. et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297\u2013303 (2001).","journal-title":"Nat. Med."},{"key":"2872_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","volume":"360","author":"F Andre","year":"2002","unstructured":"Andre, F. et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360, 295\u2013305 (2002).","journal-title":"Lancet"},{"key":"2872_CR18","doi-asserted-by":"publisher","first-page":"2308662","DOI":"10.1002\/advs.202308662","volume":"11","author":"J Han","year":"2024","unstructured":"Han, J. et al. Novel personalized cancer vaccine using tumor extracellular vesicles with attenuated tumorigenicity and enhanced immunogenicity. Adv. Sci. 11, 2308662 (2024).","journal-title":"Adv. Sci."},{"key":"2872_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1021\/acsnano.3c05645","volume":"18","author":"KH Han","year":"2024","unstructured":"Han, K. H. et al. Immunogenic extracellular vesicles derived from endoplasmic reticulum-stressed tumor cells: implications as the therapeutic cancer vaccine. ACS Nano 18, 199\u2013209 (2024).","journal-title":"ACS Nano"},{"key":"2872_CR20","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41565-025-01931-2","volume":"20","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Engineering pyroptotic vesicles as personalized cancer vaccines. Nat. Nanotechnol. 20, 1108\u20131118 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"2872_CR21","doi-asserted-by":"publisher","first-page":"114177","DOI":"10.1016\/j.addr.2022.114177","volume":"183","author":"MK Shim","year":"2022","unstructured":"Shim, M. K., Yang, S., Sun, I.-C. & Kim, K. Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery. Adv. Drug Deliv. Rev. 183, 114177 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2872_CR22","doi-asserted-by":"publisher","first-page":"2303981","DOI":"10.1002\/advs.202303981","volume":"11","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. Single-component dual-functional autoboost strategy by dual photodynamic and Cyclooxygenase-2 inhibition for lung cancer and spinal metastasis. Adv. Sci. 11, 2303981 (2024).","journal-title":"Adv. Sci."},{"key":"2872_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101759","volume":"48","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Inhibiting COX-2\/PGE2 pathway with biodegradable NIR-\u2161 fluorescent polymeric nanoparticles for enhanced photodynamic immunotherapy. Nano Today 48, 101759 (2023).","journal-title":"Nano Today"},{"key":"2872_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","volume":"162","author":"S Zelenay","year":"2015","unstructured":"Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257\u20131270 (2015).","journal-title":"Cell"},{"key":"2872_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1158\/2326-6066.CIR-16-0400","volume":"5","author":"M Hennequart","year":"2017","unstructured":"Hennequart, M. et al. Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance. Cancer Immunol. Res. 5, 695\u2013709 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"2872_CR26","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.chembiol.2024.08.010","volume":"31","author":"JA Gregory","year":"2024","unstructured":"Gregory, J. A., Hickey, C. M., Chavez, J. & Cacace, A. M. New therapies on the horizon: Targeted protein degradation in neuroscience. Cell Chem. Biol. 31, 1688\u20131698 (2024).","journal-title":"Cell Chem. Biol."},{"key":"2872_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1158\/1078-0432.CCR-15-0577","volume":"22","author":"R Koch","year":"2016","unstructured":"Koch, R. et al. Nuclear trapping through inhibition of exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and pixantrone. Clin. Cancer Res. 22, 395\u2013404 (2016).","journal-title":"Clin. Cancer Res."},{"key":"2872_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/gut.47.4.527","volume":"47","author":"G Sigthorsson","year":"2000","unstructured":"Sigthorsson, G. et al. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut 47, 527\u2013532 (2000).","journal-title":"Gut"},{"key":"2872_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/j.pain.0000000000002032","volume":"162","author":"O Summ","year":"2021","unstructured":"Summ, O. et al. Differential actions of indomethacin: clinical relevance in headache. Pain 162, 591\u2013599 (2021).","journal-title":"Pain"},{"key":"2872_CR30","doi-asserted-by":"publisher","first-page":"2405475","DOI":"10.1002\/adma.202405475","volume":"36","author":"J Choi","year":"2024","unstructured":"Choi, J. et al. Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy. Adv. Mater. 36, 2405475 (2024).","journal-title":"Adv. Mater."},{"key":"2872_CR31","doi-asserted-by":"crossref","unstructured":"Jang, Y. et al. Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy. Acta Pharm. Sin. B. 15, 4886-4899 (2025).","DOI":"10.1016\/j.apsb.2025.06.028"},{"key":"2872_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01707-5","volume":"22","author":"JM Kelm","year":"2023","unstructured":"Kelm, J. M. et al. PROTAC\u2019ing oncoproteins: targeted protein degradation for cancer therapy. Mol. Cancer 22, 62 (2023).","journal-title":"Mol. Cancer"},{"key":"2872_CR33","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41587-022-01381-4","volume":"40","author":"L Si","year":"2022","unstructured":"Si, L. et al. Generation of a live attenuated influenza A vaccine by proteolysis targeting. Nat. Biotechnol. 40, 1370\u20131377 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2872_CR34","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41587-022-01406-y","volume":"40","author":"B Gilbertson","year":"2022","unstructured":"Gilbertson, B. & Subbarao, K. A new route to vaccines using PROTACs. Nat. Biotechnol. 40, 1328\u20131329 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2872_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/nbt0906-1041","volume":"24","author":"E Waltz","year":"2006","unstructured":"Waltz, E. Companies eye slice of age-related macular degeneration market. Nat. Biotechnol. 24, 1041\u20131042 (2006).","journal-title":"Nat. Biotechnol."},{"key":"2872_CR36","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s40123-024-00952-9","volume":"13","author":"MJ Sirks","year":"2024","unstructured":"Sirks, M. J. et al. Perspectives and update on the global shortage of Verteporfin (Visudyne\u00ae). Ophthalmol. Ther. 13, 1821\u20131831 (2024).","journal-title":"Ophthalmol. Ther."},{"key":"2872_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita, S. et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature 560, 185\u2013191 (2018).","journal-title":"Nature"},{"key":"2872_CR38","doi-asserted-by":"publisher","first-page":"14698","DOI":"10.1002\/anie.201608504","volume":"55","author":"MK Shim","year":"2016","unstructured":"Shim, M. K. et al. Cathepsin B-specific metabolic precursor for invivo tumor-specific fluorescence imaging. Angew. Chem. -Int. Ed. 55, 14698\u201314703 (2016).","journal-title":"Angew. Chem. -Int. Ed."},{"key":"2872_CR39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nnano.2013.181","volume":"8","author":"S Tenzer","year":"2013","unstructured":"Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8, 772\u2013781 (2013).","journal-title":"Nat. Nanotechnol."},{"key":"2872_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","volume":"14","author":"VP Vu","year":"2019","unstructured":"Vu, V. P. et al. Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nat. Nanotechnol. 14, 260\u2013268 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"2872_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21315\/mjms2022.29.3.4","volume":"29","author":"H Rajaratinam","year":"2022","unstructured":"Rajaratinam, H. et al. Passage number of 4T1 cells influences the development of tumour and the progression of metastasis in 4T1 orthotopic mice. Malays. J. Med. Sci. 29, 30 (2022).","journal-title":"Malays. J. Med. Sci."},{"key":"2872_CR42","first-page":"6","volume":"5","author":"S Anand","year":"2019","unstructured":"Anand, S. et al. A non-toxic approach for treatment of breast cancer and its metastases: capecitabine enhanced photodynamic therapy in a murine breast tumor model. J. Cancer Metastasis Treat. 5, 6 (2019).","journal-title":"J. Cancer Metastasis Treat."},{"key":"2872_CR43","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.7150\/thno.69119","volume":"12","author":"Y Moon","year":"2022","unstructured":"Moon, Y. et al. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death. Theranostics 12, 1999\u20132014 (2022).","journal-title":"Theranostics"},{"key":"2872_CR44","doi-asserted-by":"publisher","first-page":"15336","DOI":"10.1073\/pnas.1102855108","volume":"108","author":"T Aung","year":"2011","unstructured":"Aung, T. et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc. Natl. Acad. Sci. Usa. 108, 15336\u201315341 (2011).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"2872_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23194-w","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy. Nat. Commun. 12, 2934 (2021).","journal-title":"Nat. Commun."},{"key":"2872_CR46","doi-asserted-by":"crossref","unstructured":"Ngo, J. M. et al. Extracellular vesicles and cellular homeostasis. Annu. Rev. Biochem. 94, 587-609 (2025).","DOI":"10.1146\/annurev-biochem-100924-012717"},{"key":"2872_CR47","doi-asserted-by":"crossref","unstructured":"Xiao, J. & Sluijter, J. P. Extracellular vesicles in cardiovascular homeostasis and disease: potential role in diagnosis and therapy. Nat. Rev. Cardiol. 22, 1-13 (2025).","DOI":"10.1038\/s41569-025-01141-2"},{"key":"2872_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14450-6","volume":"11","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Liver governs adipose remodelling via extracellular vesicles in response to lipid overload. Nat. Commun. 11, 719 (2020).","journal-title":"Nat. Commun."},{"key":"2872_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2017.12.001","volume":"27","author":"M Whitham","year":"2018","unstructured":"Whitham, M. et al. Extracellular vesicles provide a means for tissue crosstalk during exercise. Cell Metab. 27, 237\u2013251. e234 (2018).","journal-title":"Cell Metab."},{"key":"2872_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06964-5","volume":"20","author":"JIG Solari","year":"2020","unstructured":"Solari, J. I. G. et al. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells. BMC Cancer 20, 474 (2020).","journal-title":"BMC Cancer"},{"key":"2872_CR51","doi-asserted-by":"crossref","unstructured":"Gurunathan, S. & Kim, J. H. Graphene oxide enhances biogenesis and release of exosomes in human ovarian cancer cells. Int. J. Nanomed. 17, 5697-5731 (2022).","DOI":"10.2147\/IJN.S385113"},{"key":"2872_CR52","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1021\/acsnano.3c13143","volume":"18","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Reinforced Immunogenic Endoplasmic Reticulum Stress and Oxidative Stress via an Orchestrated Nanophotoinducer to Boost Cancer Photoimmunotherapy. ACS Nano 18, 7267\u20137286 (2024).","journal-title":"ACS Nano"},{"key":"2872_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001926","volume":"9","author":"R Alzeibak","year":"2021","unstructured":"Alzeibak, R. et al. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. J. Immunother. Cancer 9, e001926 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2872_CR54","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860\u2013875 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2872_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95\u2013112 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2872_CR56","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41565-025-01952-x","volume":"20","author":"Q You","year":"2025","unstructured":"You, Q. et al. A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy. Nat. Nanotechnol. 20, 1298\u20131311 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"2872_CR57","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41573-024-00974-9","volume":"23","author":"N Gong","year":"2024","unstructured":"Gong, N. et al. Enhancing in situ cancer vaccines using delivery technologies. Nat. Rev. Drug Discov. 23, 607\u2013625 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2872_CR58","first-page":"3816","volume":"9","author":"W Kuang","year":"2017","unstructured":"Kuang, W. et al. Hepatocyte growth factor induces breast cancer cell invasion via the PI3K\/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2. Am. J. Transl. Res. 9, 3816\u20133826 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"2872_CR59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560, 382\u2013386 (2018).","journal-title":"Nature"},{"key":"2872_CR60","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/1541-7786.MCR-20-0956","volume":"19","author":"A Shimizu","year":"2021","unstructured":"Shimizu, A. et al. Exosomal CD47 plays an essential role in immune evasion in ovarian cancer. Mol. Cancer Res. 19, 1583\u20131595 (2021).","journal-title":"Mol. Cancer Res."},{"key":"2872_CR61","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/jm0613166","volume":"50","author":"AL Blobaum","year":"2007","unstructured":"Blobaum, A. L. & Marnett, L. J. Structural and Functional Basis of Cyclooxygenase Inhibition. J. Med. Chem. 50, 1425\u20131441 (2007).","journal-title":"J. Med. Chem."},{"key":"2872_CR62","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1042\/BST0370918","volume":"37","author":"SD Selcuklu","year":"2009","unstructured":"Selcuklu, S. D., Donoghue, M. T. & Spillane, C. miR-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans. 37, 918\u2013925 (2009).","journal-title":"Biochem. Soc. Trans."},{"key":"2872_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41392-020-0206-y","volume":"5","author":"Z Gao","year":"2020","unstructured":"Gao, Z. et al. miR-24-3p promotes colon cancer progression by targeting ING1. Signal Transduct. Target. Ther. 5, 171 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2872_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01783-5","volume":"21","author":"J Lei","year":"2021","unstructured":"Lei, J. et al. M2 macrophages-derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 82. Cancer Cell Int 21, 91 (2021).","journal-title":"Cancer Cell Int"},{"key":"2872_CR65","doi-asserted-by":"publisher","first-page":"e1234","DOI":"10.1097\/DCR.0000000000002986","volume":"66","author":"Y Ding","year":"2023","unstructured":"Ding, Y. et al. M2 macrophage-derived extracellular vesicles containing MicroRNA-501-3p promote colon cancer progression through the SETD7\/DNMT1\/SOCS3 axis. Dis. Colon Rectum 66, e1234\u2013e1245 (2023).","journal-title":"Dis. Colon Rectum"},{"key":"2872_CR66","doi-asserted-by":"crossref","unstructured":"Rao, H.-c. et al. MiR-25-3p serves as an oncogenic MicroRNA by downregulating the expression of merlin in osteosarcoma. Cancer Manag. Res. 12, 8989-9001 (2020).","DOI":"10.2147\/CMAR.S262245"},{"key":"2872_CR67","doi-asserted-by":"publisher","first-page":"BSR20201901","DOI":"10.1042\/BSR20201901","volume":"40","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. MiR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K\/AKT pathway. Biosci. Rep. 40, BSR20201901 (2020).","journal-title":"Biosci. Rep."},{"key":"2872_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.992","volume":"12","author":"J Song","year":"2022","unstructured":"Song, J. et al. MiR-192-5p\/RB1\/NF-\u03baBp65 signaling axis promotes IL-10 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironment. Clin. Transl. Med. 12, e992 (2022).","journal-title":"Clin. Transl. Med."},{"key":"2872_CR69","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s12276-020-0431-z","volume":"52","author":"G Shan","year":"2020","unstructured":"Shan, G. et al. Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-\u03b2 signaling pathway. Exp. Mol. Med. 52, 1809\u20131822 (2020).","journal-title":"Exp. Mol. Med."},{"key":"2872_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fgene.2017.00031","volume":"8","author":"J Balzeau","year":"2017","unstructured":"Balzeau, J., Menezes, M. R., Cao, S. & Hagan, J. P. The LIN28\/let-7 pathway in cancer. Front. Genet. 8, 31 (2017).","journal-title":"Front. Genet."},{"key":"2872_CR71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/bjc.2017.156","volume":"117","author":"Y-X Cui","year":"2017","unstructured":"Cui, Y.-X. et al. MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells. Br. J. Cancer 117, 89\u2013101 (2017).","journal-title":"Br. J. Cancer"},{"key":"2872_CR72","doi-asserted-by":"publisher","first-page":"13414","DOI":"10.1073\/pnas.1003747107","volume":"107","author":"KE Foster","year":"2010","unstructured":"Foster, K. E. et al. EphB\u2013ephrin-B2 interactions are required for thymus migration during organogenesis. Proc. Natl. Acad. Sci. Usa. 107, 13414\u201313419 (2010).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"2872_CR73","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1172\/JCI59097","volume":"122","author":"X Li","year":"2012","unstructured":"Li, X. et al. Divergent requirement for G\u03b1s and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets. J. Clin. Invest. 122, 963\u2013973 (2012).","journal-title":"J. Clin. Invest."},{"key":"2872_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58431-z","volume":"16","author":"Z Chen","year":"2025","unstructured":"Chen, Z. et al. Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy. Nat. Commun. 16, 4095 (2025).","journal-title":"Nat. Commun."},{"key":"2872_CR75","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1002\/1873-3468.13220","volume":"592","author":"K Kim","year":"2018","unstructured":"Kim, K., Lee, J. & Ghil, S. The regulators of G protein signaling RGS 16 and RGS 18 inhibit protease-activated receptor 2\/Gi\/o signaling through distinct interactions with G\u03b1 in live cells. FEBS Lett. 592, 3126\u20133138 (2018).","journal-title":"FEBS Lett."},{"key":"2872_CR76","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1111\/cas.15123","volume":"112","author":"T Taniai","year":"2021","unstructured":"Taniai, T. et al. Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells. Cancer Sci. 112, 4570\u20134579 (2021).","journal-title":"Cancer Sci."},{"key":"2872_CR77","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.biocel.2007.03.022","volume":"39","author":"F Toledo","year":"2007","unstructured":"Toledo, F. & Wahl, G. M. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. 39, 1476\u20131482 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2872_CR78","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.4161\/cc.9.9.11535","volume":"9","author":"J Wu","year":"2010","unstructured":"Wu, J. et al. miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 9, 1809\u20131818 (2010).","journal-title":"Cell Cycle"},{"key":"2872_CR79","doi-asserted-by":"publisher","first-page":"17349","DOI":"10.18632\/aging.203225","volume":"13","author":"T Li","year":"2021","unstructured":"Li, T. et al. miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1\/2. Aging-US 13, 17349 (2021).","journal-title":"Aging-US"},{"key":"2872_CR80","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.tranon.2021.101199","volume":"14","author":"X Ma","year":"2021","unstructured":"Ma, X., Wang, N., Chen, K. & Zhang, C. Oncosuppressive role of MicroRNA-205\u20133p in gastric cancer through inhibition of proliferation and induction of senescence: Oncosuppressive role of MicroRNA-205 in gastric cancer. Transl. Oncol. 14, 101199 (2021).","journal-title":"Transl. Oncol."},{"key":"2872_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11175-9","volume":"23","author":"Z Zhenhai","year":"2023","unstructured":"Zhenhai, Z. et al. MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38\/ERK activation. BMC Cancer 23, 956 (2023).","journal-title":"BMC Cancer"},{"key":"2872_CR82","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s12282-022-01359-9","volume":"29","author":"JW Woo","year":"2022","unstructured":"Woo, J. W. et al. miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast. Breast Cancer 29, 814\u2013824 (2022).","journal-title":"Breast Cancer"},{"key":"2872_CR83","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/onc.2013.65","volume":"33","author":"R Lei","year":"2014","unstructured":"Lei, R. et al. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene 33, 1287\u20131296 (2014).","journal-title":"Oncogene"},{"key":"2872_CR84","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3389\/fonc.2020.01371","volume":"10","author":"S-J Shen","year":"2020","unstructured":"Shen, S.-J. et al. MicroRNA-27b-3p promotes tumor progression and metastasis by inhibiting peroxisome proliferator-activated receptor gamma in triple-negative breast cancer. Front. Oncol. 10, 1371 (2020).","journal-title":"Front. Oncol."},{"key":"2872_CR85","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.omtn.2021.02.027","volume":"24","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis. Mol. Ther. Nucl. Acids 24, 610\u2013621 (2021).","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"2872_CR86","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3892\/or.2015.4417","volume":"35","author":"Y Zheng","year":"2016","unstructured":"Zheng, Y. et al. MiR-181b promotes chemoresistance in breast cancer by regulating Bim expression. Oncol. Rep. 35, 683\u2013690 (2016).","journal-title":"Oncol. Rep."},{"key":"2872_CR87","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","volume":"11","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi, R. et al. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 11, 174\u2013183 (2010).","journal-title":"Lancet Oncol."},{"key":"2872_CR88","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi, Y. et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139, 3187\u20133201 (2016).","journal-title":"Brain"},{"key":"2872_CR89","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-020-00658-y","volume":"28","author":"TL Aaes","year":"2021","unstructured":"Aaes, T. L. & Vandenabeele, P. The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses. Cell Death Differ. 28, 843\u2013860 (2021).","journal-title":"Cell Death Differ."},{"key":"2872_CR90","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jama.1966.03100070075022","volume":"195","author":"NO Rothermich","year":"1966","unstructured":"Rothermich, N. O. An extended study of indomethacin: I. Clinical pharmacology. JAMA 195, 531\u2013536 (1966).","journal-title":"JAMA"},{"key":"2872_CR91","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329\u2013335 (2015).","journal-title":"Nature"},{"key":"2872_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccell.2018.12.001","volume":"35","author":"A Ortiz","year":"2019","unstructured":"Ortiz, A. et al. An interferon-driven oxysterol-based defense against tumor-derived extracellular vesicles. Cancer Cell 35, 33\u201345. e36 (2019).","journal-title":"Cancer Cell"},{"key":"2872_CR93","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn0238","volume":"8","author":"M Zatzman","year":"2022","unstructured":"Zatzman, M. et al. Widespread hypertranscription in aggressive human cancers. Sci. Adv. 8, eabn0238 (2022).","journal-title":"Sci. Adv."},{"key":"2872_CR94","first-page":"6808","volume":"62","author":"O Straume","year":"2002","unstructured":"Straume, O. et al. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res 62, 6808\u20136811 (2002).","journal-title":"Cancer Res"},{"key":"2872_CR95","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nri.2016.13","volume":"16","author":"DL Farber","year":"2016","unstructured":"Farber, D. L. et al. Immunological memory: lessons from the past and a look to the future. Nat. Rev. Immunol. 16, 124\u2013128 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2872_CR96","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature25144","volume":"552","author":"B Youngblood","year":"2017","unstructured":"Youngblood, B. et al. Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature 552, 404\u2013409 (2017).","journal-title":"Nature"},{"key":"2872_CR97","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nnano.2014.337","volume":"10","author":"E Mattia","year":"2015","unstructured":"Mattia, E. & Otto, S. Supramolecular systems chemistry. Nat. Nanotechnol. 10, 111\u2013119 (2015).","journal-title":"Nat. Nanotechnol."},{"key":"2872_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 1\u201312 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"2872_CR99","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1039\/C7CS90102J","volume":"46","author":"H Cui","year":"2017","unstructured":"Cui, H. & Xu, B. Supramolecular medicine. Chem. Soc. Rev. 46, 6430\u20136432 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"2872_CR100","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"2872_CR101","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","volume":"113","author":"J Kowal","year":"2016","unstructured":"Kowal, J. et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl. Acad. Sci. Usa. 113, E968\u2013E977 (2016).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"2872_CR102","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19\u201330 (2010).","journal-title":"Nat. Cell Biol."},{"key":"2872_CR103","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1038\/sj.onc.1208481","volume":"24","author":"C Volanti","year":"2005","unstructured":"Volanti, C. et al. Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene 24, 2981\u20132991 (2005).","journal-title":"Oncogene"},{"key":"2872_CR104","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1039\/D0BM01385D","volume":"8","author":"S Li","year":"2020","unstructured":"Li, S., Xu, J., Qian, J. & Gao, X. Engineering extracellular vesicles for cancer therapy: recent advances and challenges in clinical translation. Biomater. Sci. 8, 6978\u20136991 (2020).","journal-title":"Biomater. Sci."},{"key":"2872_CR105","doi-asserted-by":"publisher","first-page":"711565","DOI":"10.3389\/fimmu.2021.711565","volume":"12","author":"P Santos","year":"2021","unstructured":"Santos, P. & Almeida, F. Exosome-based vaccines: history, current state, and clinical trials. Front. Immunol. 12, 711565 (2021).","journal-title":"Front. Immunol."},{"key":"2872_CR106","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"2872_CR107","unstructured":"Bittencourt, S. A. FastQC: a quality control tool for high throughput sequence data. Babraham Bioinf (2011)."},{"key":"2872_CR108","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet 17, 10\u201312 (2011).","journal-title":"EMBnet"},{"key":"2872_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"2872_CR110","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"2872_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2872_CR112","first-page":"32","volume":"26","author":"MJ Anderson","year":"2001","unstructured":"Anderson, M. J. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 26, 32\u201346 (2001).","journal-title":"Austral Ecol."},{"key":"2872_CR113","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 48, D127\u2013D131 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2872_CR114","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"2872_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"2872_CR116","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41596-020-00466-1","volume":"16","author":"R Crescitelli","year":"2021","unstructured":"Crescitelli, R., L\u00e4sser, C. & L\u00f6tvall, J. Isolation and characterization of extracellular vesicle subpopulations from tissues. Nat. Protoc. 16, 1548\u20131580 (2021).","journal-title":"Nat. Protoc."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02872-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02872-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02872-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:01:11Z","timestamp":1783551671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02872-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2872"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02872-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}